Clinical Outcomes in Bacillus Calmette-Guérin-Exposed Non-Muscle-Invasive Bladder Cancer.
Giatsoglou M +4 more
europepmc +1 more source
Chronic Granulomatous Interstitial Nephritis Presenting Five Years After Intravesical Bacillus Calmette-Guérin Therapy: A Case Report and Literature Review. [PDF]
El Mansouri M +6 more
europepmc +1 more source
Evaluation of human epidermal growth factor receptor 2 (HER2)-related genes revealed that HER2-antibody-drug conjugate (ADC) drugs confer clinical benefits to Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer patients. [PDF]
Zhan W +7 more
europepmc +1 more source
Neonatal BCG and Hepatitis B Vaccination and Incidence of Atopic Dermatitis in Children by 36 Month of Age: Results of Prospective Study. [PDF]
Namazova-Baranova L +8 more
europepmc +1 more source
Provincial Trends in Childhood Vaccine Coverage in Afghanistan From 2000 to 2024: An Ecological Study of Findings From the Institute for Health Metrics and Evaluation. [PDF]
Khan A, Tidman M.
europepmc +1 more source
Related searches:
BCG INOCULATION AND BCG VACCINATION
Archives of Pediatrics and Adolescent Medicine, 1948A FEW DECADES ago the criticism passed on BCG vaccination was sharp indeed. From the United States, 1 Canada, 2 England, 3 Austria, 4 Switzerland, 5 France 6 and Sweden, 7 severe observations were made on the hypothetic clinicoimmunobiologic prerequisites for Calmette's method of vaccination and on the very optimistic and scientifically assailable ...
openaire +2 more sources
The history of tuberculosis control by vaccination with Bacille Calmette-Guérin (BCG) is reviewed. Use of the vaccine is evaluated in light of conflicting results from trials of BCG efficacy. Explanatinations are suggested for the variations between trials, and the continued use of BCG as a vaccine against tuberculosis is discussed.
openaire +3 more sources

